There are numerical errors in the first and penultimate sentences of the second paragraph of the Results under the subheading "Rapid identification and susceptibility test performances." The correct paragraph is: βLT performed on 164 BSI (P1 and P2 combined) yielded 24 positive, 139 negative and 1 uninterpretable test result due to an incoherent color change of the chromogenic test. All positive βLT results were found in non-natural AmpC EB isolates displaying third generation cephalosporin resistance by complete AST results and subsequently confirmed as ESBL producers. In 7 cases, βLT yielded false-negative results since complete AST and molecular testing identified 6 AmpC producing *Escherichia coli* and 1 VIM metallo-beta-lactamase-producing *P*. *aeruginosa*, all resistant to third generation cephalosporin. Globally, sensitivity and specificity of βLT were respectively 77.4% and 100%. No erroneous or uninterpretable results were observed with PBP2a testing. Performed on 25 *S*. *aureus* BSI in P1 and P2, PBP2a was able to detect all 3 MRSA strains (sensitivity and specificity of 100%). Ultimately, 8 BSI (6 in P1 and 2 in P2) were discarded from outcome analysis due to erroneous/uninterpretable rapid test results.

Tables [1](#pone.0160537.t001){ref-type="table"} and [2](#pone.0160537.t002){ref-type="table"} appear incorrectly in the published article. Please see the correct Tables [1](#pone.0160537.t001){ref-type="table"} and [2](#pone.0160537.t002){ref-type="table"} and their captions here.
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###### Distribution of microorganisms and main resistances of all bloodstream infections across the three study periods.

3GC, third generation cephalosporin (cefotaxime, ceftriaxone, ceftazidime); AST, antimicrobial susceptibility testing; BSI, bloodstream infection; carbapenem (imipenem, meropenem); ID, identification; P0, pre-intervention period; P1, intervention period 1; P2, intervention period 2. Natural AmpC producers identified during the study periods: *Citrobacter freundii*, *Enterobacter aerogenes*, *Enterobacter cloacae*, *Hafnia alvei*, *Serratia marcescens*. Non-natural AmpC producers identified during the study periods: *Citrobacter koseri*, *Escherichia coli*, *Klebsiella oxytoca*, *Klebsiella pneumoniae*, *Proteus mirabilis*, *Proteus vulgaris*, *Salmonella spp*.
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  Microorganism Resistance               P0              P1              P2                                         
  -------------------------------------- --------------- --------------- -------- ------- ---------------- -------- -------
  **Gram-positive bacteria**             **50 (37.3)**   **40 (35.7)**   **8**    **0**   **44 (28.6)**    **7**    **0**
   *Staphylococci*                       25              22              3        0       24               2        0
    *Staphylococcus aureus*              14              11              1        0       14               0        0
     methicillin                         1               1               0        \-      2                \-       \-
    Coagulase negative *Staphylococci*   11              11              2        0       10               2        0
   *Enterococci*                         12              11              1        0       9                1        0
   *Streptococci*                        9               7               2        0       10               4        0
   Other Gram-positive bacteria          4               0               2        0       1                0        0
  **Gram-negative bacteria**             **77 (57.5)**   **71 (63.4)**   **1**    **6**   **107 (69.5)**   **2**    **2**
   Enterobacteriaceae                    71              63              0        5       103              1        2
    natural AmpC producers               5               6               0        0       11               0        0
     3GC                                 2               1               \-       \-      4                \-       \-
     carbapenem                          0               0               \-       \-      0                \-       \-
    non-natural AmpC producers           66              57              0        5       92               1        2
     3GC                                 10              6               \-       5       18               0        2
     carbapenem                          0               0               \-       0       0                0        0
   Non fermenters                        6               6               1        1       4                1        0
    *Pseudomonas aeruginosa*             3               4               0        1       3                1        0
     3GC                                 0               0               \-       1       0                0        \-
     carbapenem                          0               0               \-       1       0                0        \-
    Other non fermenters                 3               2               1        0       **1**            0        0
   Other Gram-negative bacteria          0               2               \-       0       **0**            0        0
  **Anaerobes**                          **6 (4.5)**     **0 (0.0)**     **6**    **0**   **2 (1.3)**      **6**    **0**
  **Yeast**                              **1 (0.7)**     **1 (0.9)**     **2**    **0**   **1 (0.6)**      **3**    **0**
  **TOTAL**                              **134 (100)**   **112 (100)**   **17**   **6**   **154 (100)**    **18**   **2**
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###### Time to identification and time to partial/complete susceptibility results of all bloodstream infections during pre-intervention and intervention period 1 and 2.
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  -------------------------------------------- -------------------------------------- --------- ------------------------------------------------------------
  Time to identification                                                                        
  Phase                                        Method                                 BSI (n)   Mean time to ID (hours)
  **P0**                                       **TOTAL**                              **134**   **28.3**
                                               Subculture MALDI-TOF MS                134       28.3
                                               Early MALDI-TOF MS                     \-        \-
                                               Direct MALDI-TOF MS                    \-        \-
  **P1**                                       **TOTAL**                              **112**   **10.2**
                                               Subculture MALDI-TOF MS                23        15.9
                                               Early MALDI-TOF MS                     65        10.6
                                               Direct MALDI-TOF MS                    24        3.6
  **P2**                                       **TOTAL**                              **154**   **10.8**
                                               Subculture MALDI-TOF MS                32        17.1
                                               Early MALDI-TOF MS                     96        10.7
                                               Direct MALDI-TOF MS                    26        4.0
  **Time to complete susceptibility result**                                                    
  Phase                                        Method                                 BSI (n)   Mean time to complete AST result (hours)
  **P0**                                       **TOTAL**                              **134**   **44.7**
                                               Phoenix from subculture                58        46.9
                                               Phoenix from young subculture          \-        \-
                                               Direct Phoenix                         48        28.3
                                               Manual testing from subculture         28        68.3
                                               Manuel testing from young subculture   \-        \-
  **P1**                                       **TOTAL**                              **112**   **32.4**
                                               Phoenix from subculture                28        41.2
                                               Phoenix from young subculture          23        32.2
                                               Direct Phoenix                         45        25.6
                                               Manual testing from subculture         7         49.1
                                               Manuel testing from young subculture   9         27.3
  **P2**                                       **TOTAL**                              **154**   **32.6**
                                               Phoenix from subculture                34        41.6
                                               Phoenix from young subculture          81        29.9
                                               Direct Phoenix                         22        22.2
                                               Manual testing from subculture         8         52.2
                                               Manuel testing from young subculture   9         30.9
  **Time to partial susceptibility result**                                                     
  Phase                                        Method                                 BSI (n)   Mean time to partial susceptibility testing result (hours)
  **P1**                                       **TOTAL**                              **72**    **11.8**
                                               Culture βLT                            20        17.9
                                               Young subculture βLT                   29        11.2
                                               Direct βLT                             12        3.7
                                               Culture PBP2a                          3         15.3
                                               Young subculture PBP2a                 6         12
                                               Direct PBP2a                           2         2
  **P2**                                       **TOTAL**                              **109**   **11.7**
                                               Culture βLT                            29        16.8
                                               Young subculture βLT                   51        11.1
                                               Direct βLT                             15        3.6
                                               Culture PBP2a                          4         20.2
                                               Young subculture PBP2a                 9         8.8
                                               Direct PBP2a                           1         6
  -------------------------------------------- -------------------------------------- --------- ------------------------------------------------------------
